California Institute of Technology
Pasadena, California, United States
Purpose
to develop a genetically encodable alternative to eCD4-Ig that could be utilized for affordable HIV therapeutic vaccination strategies in low- and middle-income countries
Division
Global Health
Date
June 2023
Region Served
GLOBAL
Committed amount
$1,517,241
Grant topic
Create Novel Technology Platform Capabilities
Duration (months)
36
Grantee location
Pasadena, California, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.